Donepezil, an acetylcholinesterase inhibitor currently indicated for use in patients with mild to moderate AD, has recently been evaluated in VaD.

Conclusions: Donepezil-treated patients demonstrated significant improvements in cognition and global function compared with placebo-treated patients, and ...

In this study, patients with VaD treated with donepezil 5 mg or 10 mg once daily demonstrated significant benefits over placebo-treated patients on measures of ...

11 сент. 2003 г. · These data demonstrate that donepezil is an effective and well-tolerated treatment for VaD and show it may have an important place in the management of this ...

22 февр. 2021 г. · We found moderate- to high-certainty evidence that donepezil 5 mg, donepezil 10 mg, and galantamine have a slight beneficial effect on cognition in people with ...

1 мая 1999 г. · Among patients with VaD, improvement or stabilization in cognition and behavior occurred after treatment with donepezil. Moreover, the drug was ...

25 янв. 2002 г. · Treatment with ARICEPT® (donepezil hydrochloride tablets) significantly improved the cognitive and global (overall) function of patients with vascular dementia ...

14 июл. 2021 г. · Aricept is a brand-name prescription drug. The FDA has approved it to treat dementia due to mild, moderate, or severe Alzheimer's disease in adults. Dosage · FAQs · Uses · Aricept and alcohol

In patients with vascular dementia, treatment with donepezil produces small, but not clinically significant, changes in cognitive function.

Alzheimer's disease medicines, such as donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon) or memantine are not used to treat vascular dementia, ...